Table 2 Mean weight loss from baseline to 6 months (ITT and per protocol primary outcome analysis).

From: Non-invasive vestibular nerve stimulation (VeNS) reduces visceral adipose tissue: results of a randomised controlled trial

 

Active device n = 117

Sham device n = 124

Difference in LSmeans (95% CI)

p-value

LSmean

LSmean

% change in weight

    

ITT analysis

−2.91

−2.30

−0.61 (−2.00, 0.79)

0.394

Per-protocol analysis*

−3.16

−2.32

−0.84 (−2.32, 0.64)

0.266

  1. *Per protocol population (Active Device = 83 and Sham Device = 87) excludes participants who did not use the device for an average of 3.5 h a week for at least 4 of the first 6 months. Linear regression model adjusted for baseline weight and gender. LSmeans, Least square means; ITT, Intention to Treat analysis.
Back to article page